Regencell Bioscience Holdings Limited
RGC
Clasificación en acciones
#3381
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Precio por acción
$10.41
Última sincronización: 2026-10-20
Capitalización bursátil
$5.16B
Cambio (1 día)
3.56%
Cambio (1 año)
-35.07%
País
HK
Comercio Regencell Bioscience Holdings Limited (RGC)
Categoría
Healthcare
Ratio P/B de Regencell Bioscience Holdings Limited (RGC)
Ratio P/B al October 2026 TTM: 300.54
Según los informes financieros más recientes y el precio de las acciones de Regencell Bioscience Holdings Limited, el ratio P/B actual (TTM) es 300.54. Al final de 2024, el ratio P/B era 5.08.
Historial del ratio P/B de Regencell Bioscience Holdings Limited desde 2019 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 300.54 | -82.66% |
| 2025 | 1.73K | 34,010.49% |
| 2024 | 5.08 | -79.61% |
| 2023 | 24.92 | -5.54% |
| 2022 | 26.38 | -179.45% |
| 2021 | -33.21 | -33.69% |
| 2020 | -50.08 | -30.65% |
| 2019 | -72.20 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -98.32% |
IN
|
